skip to content

Wellcome - MRC Cambridge Stem Cell Institute

 

Severe infections wreak havoc on mouse blood cell production

23 November 2020

Severe infections like malaria cause short and long-term damage to precursor blood cells in mice, but some damage could be reversed, find researchers. A team led by researchers from Imperial College London, The Francis Crick Institute and the Wellcome – MRC Cambridge Stem Cell Institute have discovered that severe...

Read more

Uncovering Network Control of Blood Cell Production

26 October 2020

Blood stem and progenitor cells are responsible for the constant production of red and white blood cells, and also platelets, with millions of these blood cells being produced every second. Disruption of this blood cell production system can lead to diseases such as leukaemia, a type of blood cancer caused by a rapid overproduction of abnormal white blood cells.

Read more

‘Mini-lungs’ reveal early stages of SARS-CoV-2 infection

23 October 2020

To better understand how SARS-CoV-2 infects the lungs and causes disease, a team of scientists from the Cambridge Stem Cell Institute and collaborators in South Korea turned to organoids – ‘mini-organs’ grown in three dimensions to mimic the behaviour of tissue and organs.

Read more

Uncovering new therapeutic interventions for Multiple Sclerosis

Uncovering new therapeutic interventions for Multiple Sclerosis

28 September 2020

Results from a Phase 2 trial, based on underpinning research from the Franklin lab have shown that remyelination is possible in humans. These results are being built on in a new clinical trial funded by the MS Society, based on further research from the Franklin group, involving the diabetes drug metformin and the antihistamine clemastine.

Read more

Dr Sanjay Sinha featured in Surgeons: Edge of Life on BBC 2

Dr Sanjay Sinha featured in Surgeons: Edge of Life on BBC 2

25 September 2020

Dr Sanjay Sinha, group leader at the Cambridge Stem Cell Institute and Cardiologist at Addenbrooke’s Hospital, was featured in the latest series on Surgeons: Edge of Life aired on BBC 2 on the 20th of October.

Read more

Spinout company Stroma Biosciences selected to take place in Accelerate@Babraham Start-up Programme

Spinout company Stroma Biosciences selected to take place in Accelerate@Babraham Start-up Programme

22 September 2020

Spinout company Stroma Biosciences, co-founded by Cambridge Stem Cell Institute and Department of Haematology PI Dr Ingo Ringshausen and post-doc Dr Eugene Park has been selected as one of four start-up companies taking part in the Accelerate@Babraham Start-up Programme.

Read more

Stem Cell Institute PIs awarded funding for UK/Japan collaborative projects in regenerative medicine

Stem Cell Institute PIs awarded funding for UK/Japan collaborative projects in regenerative medicine

22 September 2020

Stem Cell Institute PIs and affiliates have been awarded funding from MRC-AMED joint call for collaborations between academics in the UK and Japan in the field of regenerative medicine and stem cell research.

Read more

‘The Blood of the Future Could be Made in a Lab’ – Dr Cédric Ghevaert interviewed by the Wall Street Journal

‘The Blood of the Future Could be Made in a Lab’ – Dr Cédric Ghevaert interviewed by the Wall Street Journal

9 September 2020

In their latest The Future of Everything podcast, the Wall Street Journal explore the possibility of making blood in the lab and feature an interview with Cambridge Stem Cell Institute PI Dr Cédric Ghevaert.

Read more

Towards precision medicine: Funding awarded from the Rosetrees Trust for project focussing on patients with myeloid stem cell cancers

Towards precision medicine: Funding awarded from the Rosetrees Trust for project focussing on patients with myeloid stem cell cancers

30 July 2020

Group Leader Dr Jyoti Nangalia has been awarded funding from the Rosetrees Trust for her project “Towards precision medicine: Integrating personalised prognostic predictions for patients with myeloid stem cell cancers into clinical care.”

Read more

Stem Cell Institute Group Leaders elected as EMBO members

Stem Cell Institute Group Leaders elected as EMBO members

6 July 2020

Two Cambridge Stem Cell Institute Group Leaders are among the 63 scientists from around the world elected this year as Members and Associate Members of the European Molecular Biology Organisation (EMBO).

Read more